5 completed, 1 suspended, 1 unknown. 7 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 5, Suspended 1, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
Follow Ovarian Hyperstimulation Syndrome: new trials by email Literature Review of Ovarian Hyperstimulation Syndrome trials Research Report on Ovarian Hyperstimulation Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response Fludrocortisone 0.1 Milligrams (mg), Bromocriptine - Ovarian Hyperstimulation Syndrome | Phase 2 | Completed | Ganin Fertility Center | 107 | 2019-04-01 | 2020-04-17 |
| Montelukast for Prevention & Treatment of OHSS dydrgesterone 10 mg( tab)/12hs/14 days, montelukast 10 mg(tab) oral/24hs/ 7 days dydrgesterone 10 mg( tab) oral/12hs/14 days - Ovarian Hyperstimulation Syndrome | Phase 2 | Suspended | Benha University | 20 | 2018-12-05 | 2022-09-21 |
| Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome bromocriptine, dexamethasone - Ovarian Hyperstimulation Syndrome | Phase 2 | Unknown | Sun Yat-sen University | 200 | 2016-08-01 | 2016-07-27 |
| Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome Methylprednisolone, Control - Ovarian Hyperstimulation Syndrome | Phase 1 / Phase 2 | Completed | Royan Institute | 218 | 2009-10-01 | 2011-07-15 |
| Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program Cabergoline, Control - Ovarian Hyperstimulation Syndrome | Phase 1 / Phase 2 | Completed | Royan Institute | 10 | 2009-06-01 | 2015-05-06 |
| Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation Syndrome Quinagolide - Ovarian Hyperstimulation Syndrome | Phase 2 | Completed | Instituto Valenciano de Infertilidad, IVI VALENCIA | 30 | 2008-05-01 | 2009-09-17 |
| Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide Norprolac - Ovarian Hyperstimulation Syndrome | Phase 2 | Completed | Ferring Pharmaceuticals | 182 | 2006-06-01 | 2011-05-19 |
Adnexal Diseases (7) · Endocrine System Diseases (7) · Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Genital Diseases (7) · Genital Diseases, Female (7) · Gonadal Disorders (7) · Ovarian Diseases (7) · Urogenital Diseases (7)
Bromocriptine (2) · quinagolide (2) · Cabergoline (1) · Dexamethasone (1) · Methylprednisolone (1) · Tablets (1) · montelukast (1)
Royan Institute (2) · Benha University (1) · Ferring Pharmaceuticals (1) · Ganin Fertility Center (1) · Instituto Valenciano de Infertilidad, IVI VALENCIA (1) · Sun Yat-sen University (1)
Egypt (2) · Iran (2) · Spain (2) · China (1)
Ashraf Moini, MD (2) · Marzieh Shiva, MD (2) · Eniseh Tehraninejad, MD (1) · Haitao Zeng (1) · Hosam Zaki, MSc, FRCOG (1) · Hossam Elattar, MBBCH (1) · Muhammad S Zeafan, MBBCH (1)